Molecular imaging can improve therapeutic management of pancreatic ductal adenocarcinomas

By | July 8, 2021
For patients with pancreatic ductal adenocarcinomas (PDAC), molecular imaging can improve staging and clinical management of the disease, according to research published in the June issue of The Journal of Nuclear Medicine.